Cencora, Inc. $COR Shares Bought by Kestra Advisory Services LLC

Kestra Advisory Services LLC grew its position in Cencora, Inc. (NYSE:COR) by 86.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,691 shares of the company’s stock after acquiring an additional 7,716 shares during the quarter. Kestra Advisory Services LLC’s holdings in Cencora were worth $5,012,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Deutsche Bank AG bought a new position in shares of Cencora during the second quarter valued at approximately $286,673,000. SEB Asset Management AB purchased a new stake in shares of Cencora in the first quarter worth approximately $134,139,000. Wedge Capital Management L L P NC raised its holdings in shares of Cencora by 31.0% in the second quarter. Wedge Capital Management L L P NC now owns 105,614 shares of the company’s stock worth $29,887,000 after buying an additional 24,968 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Cencora during the 2nd quarter worth approximately $841,000. Finally, Peachtree Investment Partners LLC bought a new stake in shares of Cencora during the 2nd quarter worth approximately $2,204,000. Institutional investors own 97.52% of the company’s stock.

Analyst Ratings Changes

COR has been the topic of several research analyst reports. Bank of America upped their price objective on Cencora from $285.00 to $310.00 in a research report on Tuesday, July 21st. Morgan Stanley lifted their target price on Cencora from $346.00 to $377.00 and gave the stock an “overweight” rating in a research report on Friday, October 30th. Weiss Ratings upgraded Cencora from a “buy (b-)” rating to a “buy (b)” rating in a research report on Tuesday, October 6th. Argus boosted their target price on shares of Cencora from $340.00 to $380.00 and gave the company a “buy” rating in a research note on Tuesday, October 20th. Finally, JPMorgan Chase & Co. upped their price target on shares of Cencora from $390.00 to $413.00 and gave the stock an “overweight” rating in a report on Tuesday. Twelve research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $368.14.

Insider Transactions at Cencora

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $324.12, for a total value of $3,662,556.00. Following the completion of the sale, the executive vice president directly owned 19,455 shares in the company, valued at approximately $6,305,754.60. This trade represents a 36.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.38% of the stock is owned by corporate insiders.

Cencora Price Performance

COR opened at $349.32 on Friday. The firm has a market capitalization of $66.66 billion, a PE ratio of 19.47, a price-to-earnings-growth ratio of 1.81 and a beta of 0.58. The company has a debt-to-equity ratio of 3.01, a current ratio of 0.94 and a quick ratio of 0.59. The business’s 50-day moving average is $326.68 and its two-hundred day moving average is $317.19. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $4.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.58 by $0.08. The firm had revenue of $88.35 billion for the quarter, compared to the consensus estimate of $87.95 billion. Cencora had a net margin of 1.03% and a return on equity of 110.72%. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.84 EPS. Research analysts anticipate that Cencora, Inc. will post 19.58 earnings per share for the current fiscal year.

Cencora Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, November 13th. This represents a $2.64 annualized dividend and a yield of 0.8%. This is an increase from Cencora’s previous quarterly dividend of $0.60. Cencora’s dividend payout ratio is currently 13.39%.

About Cencora

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.